FDA approves latex underwear to protect against STIs

The US Food and Drug Administration has given its approval to Lorals, the maker of ultra-thin underwear intended to prevent sexually transmitted infections during oral sex. This is the first time the FDA has approved the use of underwear to prevent STIs.

According to the New York Times, the Los Angeles-based company was cleared by the FDA on Thursday, about four years after it was founded by its current CEO, Melanie Cristol. The brand offers a range of bikini and “shortie” underwear in “ultra-thin and silky” latex. According to the Lorals website, the products are intended to provide the desired sensation of oral sex without skin-to-skin contact, effectively reducing the risk of STIs and harmful pathogens.

The company did not have to conduct clinical trials; However, Cristol said that to receive FDA clearance, Lorals’ team had to prove that its products were as effective as dental dams – a thin sheet of rubber that forms a barrier between the mouth and genitals for oral sex.

“We had to meet physical requirements such as dimensions, thickness, elasticity, strength and absence of holes,” Cristol told the outlet. “Then we had to test its compatibility with the human body. We therefore carried out toxicity tests, irritation tests and sensitization tests.

Lorals for Protection is available in packs of four starting at $25. Disposable underwear is vanilla scented and stretchy enough to fit a wide range of body types (sizes 0-20). You can read more about the product here.

Comments are closed.